A detailed history of Janus Henderson Group PLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Janus Henderson Group PLC holds 38,443 shares of BDX stock, worth $8.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
38,443
Previous 47,814 19.6%
Holding current value
$8.98 Million
Previous $11.7 Million 18.41%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $2.19 Million - $2.32 Million
-9,371 Reduced 19.6%
38,443 $9.51 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $307,950 - $354,346
-1,326 Reduced 2.7%
47,814 $11.7 Million
Q3 2023

Nov 14, 2023

SELL
$254.9 - $283.59 $871,758 - $969,877
-3,420 Reduced 6.51%
49,140 $12.7 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $2.04 Million - $2.27 Million
8,538 Added 19.39%
52,560 $13.9 Million
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $13 Million - $14.7 Million
-56,647 Reduced 56.27%
44,022 $10.9 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $14.1 Million - $16.6 Million
64,754 Added 180.3%
100,669 $25.6 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $105,581 - $546,691
-2,069 Reduced 5.45%
35,915 $8 Million
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $17.7 Million - $20.7 Million
-75,338 Reduced 66.48%
37,984 $9.37 Million
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $2.33 Million - $2.59 Million
9,565 Added 9.22%
113,322 $30.1 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $6.57 Million - $7.17 Million
28,565 Added 37.99%
103,757 $26.1 Million
Q3 2021

Nov 16, 2021

SELL
$232.72 - $256.47 $4.54 Million - $5 Million
-19,499 Reduced 20.59%
75,192 $18.5 Million
Q2 2021

Aug 16, 2021

SELL
$232.65 - $254.58 $4.77 Million - $5.22 Million
-20,495 Reduced 17.79%
94,691 $23 Million
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $20.1 Million - $22.2 Million
-86,431 Reduced 42.87%
115,186 $28 Million
Q4 2020

Feb 16, 2021

SELL
$221.92 - $245.94 $6.94 Million - $7.69 Million
-31,284 Reduced 13.43%
201,617 $50.5 Million
Q3 2020

Nov 16, 2020

BUY
$215.77 - $276.76 $8.12 Million - $10.4 Million
37,613 Added 19.26%
232,901 $54.2 Million
Q2 2020

Aug 14, 2020

BUY
$219.9 - $263.41 $24.6 Million - $29.5 Million
111,990 Added 134.45%
195,288 $46.7 Million
Q1 2020

May 14, 2020

SELL
$195.69 - $279.01 $9.8 Million - $14 Million
-50,103 Reduced 37.56%
83,298 $19.1 Million
Q4 2019

Feb 18, 2020

SELL
$236.45 - $266.82 $66 Million - $74.4 Million
-278,965 Reduced 67.65%
133,401 $36.3 Million
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $55.4 Million - $61.5 Million
-240,117 Reduced 36.8%
412,366 $102 Million
Q2 2019

Jul 31, 2019

SELL
$217.4 - $246.08 $30.4 Million - $34.4 Million
-139,733 Reduced 17.64%
652,483 $164 Million
Q1 2019

Apr 30, 2019

BUY
$206.05 - $248.17 $5.69 Million - $6.85 Million
27,619 Added 3.61%
792,216 $198 Million
Q4 2018

Feb 06, 2019

SELL
$204.73 - $257.93 $47 Million - $59.2 Million
-229,601 Reduced 23.09%
764,597 $172 Million
Q3 2018

Nov 09, 2018

SELL
$233.07 - $256.0 $11 Million - $12.1 Million
-47,144 Reduced 4.53%
994,198 $259 Million
Q2 2018

Aug 10, 2018

SELL
$208.1 - $233.85 $67.7 Million - $76.1 Million
-325,335 Reduced 23.8%
1,041,342 $249 Million
Q1 2018

May 14, 2018

SELL
$205.46 - $240.27 $32.6 Million - $38.1 Million
-158,596 Reduced 10.4%
1,366,677 $296 Million
Q4 2017

Feb 09, 2018

BUY
$189.0 - $222.64 $54.1 Million - $63.8 Million
286,372 Added 23.12%
1,525,273 $327 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $5.24 Million - $5.58 Million
28,064 Added 2.32%
1,238,901 $0
Q2 2017

Aug 17, 2017

BUY
N/A
1,210,837
1,210,837 $236 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.